1、Cell-cycle and DNA-damage response pathway is involved in leptomeningeal metastasis of non-small cell lung cancer.,范云,范云,Clin Cancer Res.,SCI ,2018-01,浙江省肿瘤医院,1区,8.911,209–216
2、PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy. ,陈凯燕,范云,Lung Cancer.,SCI ,2020-04,浙江省肿瘤医院,2区,4.5211,98–105
3、 Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective study. ,徐艳珺,范云,Br J Cancer.,SCI ,2019-09,浙江省肿瘤医院,2区,5.416,640–646
4、The efficacy and safety of anti-PD-1/PD-L1 antibodies combined with chemotherapy or CTLA4 antibody as a first-line treatment for advanced lung cancer.,徐晓玲,范云,International Journal of Cancer,SCI ,2018-06,浙江省肿瘤医院,2区,4.982 ,2344–2354
5、Applicability of the lung-molGPA index in non-small cell lung cancer patients with different gene alterations and brain metastases. ,陈凯燕,范云,Lung Cancer.,SCI ,2018-11,浙江省肿瘤医院,2区,4.5211,8–13
6、Real-World Data on Prognostic Factors for Overall Survival in EGFR-Mutant Non-Small-Cell Lung Cancer Patients with Brain Metastases.,俞晓晴,范云,ournal of Cancer,SCI ,2019-06,浙江省肿瘤医院,3区,3.182,3486–3493
|
1、NTRK1甲基化异常在EGFR突变NSCLC患者中枢神经系统转移中的作用及分子机制研究,范云,浙江省肿瘤医院,国家自然科学基金,面上项目,2020-01,2023-12,55,55
2、PIK3CA在 EGFR 突变NSCLC患者中枢神经系统转移中的作用研究（LGF18H160017）,范云,浙江省肿瘤医院,浙江省自然科学基金,公益技术研究计划社会发展,2018-01,2020-12,15,15
|